11 September, 2017
Cowen and Company's price target would suggest a potential upside of 11.32% from the stock's current price. About shares traded. Arthur J Gallagher & Co (NYSE:AJG) has risen 17.09% since September 11, 2016 and is uptrending. Kempen Capital Management acquired 26,950 shares as Abbvie Inc Com (ABBV)'s stock rose 6.17%. The institutional investor held 423,075 shares of the consumer services company at the end of 2016Q4, valued at $15.94M, up from 363,782 at the end of the previous reported quarter. Abbvie Inc now has $136.04 billion valuation. The stock rose 1.03% or $0.88 reaching $86.22 per share.
AbbVie Inc. (AbbVie), launched on April 10, 2012, is a research-based biopharmaceutical company. It has underperformed by 6.07% the S&P500. It also reduced its holding in Williams Sonoma Inc (NYSE:WSM) by 81,595 shares in the quarter, leaving it with 596,550 shares, and cut its stake in Eastman Chemical Co (NYSE:EMN). It also reduced Wells Fargo & Co New Com (NYSE:WFC) stake by 230,300 shares and now owns 198,300 shares. The company reported $1.42 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.40 by $0.02. Its down 0.05, from 1.03 in 2016Q3. It increased, as 90 investors sold AAPL shares while 975 reduced holdings. Texas Permanent School Fund holds 53,305 shares or 0.04% of its portfolio. Exane Derivatives divested its ownership by shedding 12,571 shares a decrease of 23.7% from 03/31/2017 to 06/30/2017. Premier Asset Managment Ltd Co invested in 0.45% or 27,725 shares. Vanguard Group Inc. now owns 115,920,673 shares of the company's stock valued at $8,405,409,000 after acquiring an additional 3,706,941 shares during the last quarter. Tahithromos Ltd Llc reported 3.47% of its portfolio in Apple Inc. Tiaa Cref Trust Fsb Mo accumulated 171,065 shares. (USA) (NASDAQ:STKL). Domini Impact Invests Limited holds 7.69% in SunOpta, Inc. The Arkansas-based Commercial Bank Of The Ozarks has invested 0.84% in AbbVie Inc (NYSE:ABBV). Acropolis Investment Management LLC bought a new stake in shares of AbbVie in the 2nd quarter valued at about $106,000. Aull And Monroe Inv Management stated it has 30,204 shares. Asset Mngmt One Ltd owns 9.46M shares for 2.71% of their portfolio. Moreover, Prentiss Smith has 0.28% invested in AbbVie Inc (NYSE:ABBV). (NASDAQ:AAPL). Private Harbour Invest & Counsel Limited Liability Com has 6,213 shares for 0.65% of their portfolio.
Since May 4, 2017, it had 0 insider buys, and 5 sales for $18.84 million activity. First Personal Financial Services now owns 2,236 shares of the company's stock valued at $138,000 after buying an additional 1,028 shares during the last quarter. SCHILLER PHILIP W sold $6.85M worth of Apple Inc. Schroder Group owns 1.03 million shares. Orbimed holds 2.33% in AbbVie Inc (NYSE:ABBV) or 2.93 million shares.
AbbVie (NYSE:ABBV) last issued its earnings results on Friday, July 28th. The stock of Apple Inc. BMO Capital Markets reiterated a "market perform" rating and issued a $66.00 price objective on shares of AbbVie in a research report on Wednesday, May 17th. Morgan Stanley holds 0.02% in SunOpta, Inc. The company was maintained on Friday, June 2 by Drexel Hamilton. The firm has "Outperform" rating given on Wednesday, July 27 by RBC Capital Markets. The company was maintained on Friday, October 23 by UBS. The company was downgraded on Monday, June 12 by Mizuho. SunTrust initiated the stock with "Buy" rating in Wednesday, July 22 report.
Investors sentiment decreased to 1.24 in 2016 Q4. Its up 0.01, from 0.99 in 2016Q3. Finally, Tradewinds Capital Management LLC raised its position in AbbVie by 87.2% during the 1st quarter. Following the completion of the sale, the chairman now owns 342,353 shares of the company's stock, valued at approximately $24,313,910.06. Tirschwell & Loewy Incorporated holds 130,066 shares. 4,204,517 shares of the company were exchanged. Northwestern Mutual Wealth Management invested in 0% or 5,841 shares. Barrington Strategic Wealth Management Group Ltd reported 0.36% stake. The shares were sold at an average price of $71.00, for a total value of $4,676,131.00. AbbVie Inc. The company has a market capitalization of $97.51 billion, a price-to-earnings ratio of 16.53 and a beta of 1.58. Next Fincl Grp holds 150 shares. Another trade for 5,800 shares valued at $51,872 was made by Duchscher Robert on Friday, May 19. It also increased its holding in Pepsico Inc (NYSE:PEP) by 4,953 shares in the quarter, for a total of 57,209 shares, and has risen its stake in Ishares Tr (TLT).
Among 2 analysts covering Syncordia Technologies (CVE:SYN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 42% are positive. Atwood & Palmer Inc. raised its position in AbbVie by 1,333.3% during the 1st quarter. The stock of AbbVie Inc (NYSE:ABBV) has "Hold" rating given on Tuesday, March 15 by Deutsche Bank. The stock now has a consensus rating of "Buy" and a consensus target price of $79.25. The rating was initiated by Raymond James with "Outperform" on Friday, September 2. Finally, BidaskClub upgraded shares of AbbVie from a "buy" rating to a "strong-buy" rating in a research report on Saturday, June 10th. First Bancorp Of Omaha stated it has 0.07% in AbbVie Inc (NYSE:ABBV). AbbVie has a consensus rating of "Hold" and an average target price of $70.25.
In the past 5 years, the stock showed growth of 16.99% per annum.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.